ArticleScientific reports2026
Fe-W co-doped V
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanoparticles of V2O5 with dilute doped Fe-, W-, and Fe-W co-doped were prepared by using wet chemical sol–gel method. Structural analysis confirmed the dominant orthorhombic α-V2O5 phase with a minor monoclinic V3O7 phase, whose fraction increased with doping. Rietveld refinement, and electron density (ED) mapping revealed balanced structural distortion, a strong synergistic effect and enhanced phase stability in Fe-W co-doped V2O5. Optical studies showed enhanced visible-light absorption and a reduced bandgap from 2.32 eV (pristine) to 2.14 eV (co-doped), and the formation of shallow and deep defect states that improve charge transfer and suppress recombination. Co-doping induced a morphological transformation from aggregated nanorods to porous, well-aligned nanowires with uniform elemental distribution. Electronic structures confirmed increased V4+ concentration and higher oxygen vacancy density, optimizing redox active sites. Thus, defect engineering and dual-phase evolution synergistically enhance the photocatalytic performance of co-doped V2O5. Consequently, the co-doped V2O5 sample showed exhibited superior photocatalytic performance, following pseudo-first-order kinetics, achieving 99.25% of MB and 98.1% of MO dyes in 30 min under direct sun light.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.